KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Guardant Health (GH) Equity Average (2018 - 2026)

Guardant Health's Equity Average history spans 8 years, with the latest figure at -$226.9 million for Q4 2025.

  • On a quarterly basis, Equity Average fell 127.18% to -$226.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$226.9 million, a 127.18% decrease, with the full-year FY2025 number at -$119.5 million, down 1355.21% from a year prior.
  • Equity Average hit -$226.9 million in Q4 2025 for Guardant Health, up from -$330.0 million in the prior quarter.
  • Over the last five years, Equity Average for GH hit a ceiling of $1.1 billion in Q1 2021 and a floor of -$330.0 million in Q3 2025.
  • Historically, Equity Average has averaged $213.0 million across 5 years, with a median of $118.8 million in 2023.
  • Biggest five-year swings in Equity Average: soared 1352.23% in 2024 and later tumbled 969.45% in 2025.
  • Tracing GH's Equity Average over 5 years: stood at $677.2 million in 2021, then plummeted by 83.25% to $113.5 million in 2022, then surged by 70.53% to $193.5 million in 2023, then crashed by 151.62% to -$99.9 million in 2024, then plummeted by 127.18% to -$226.9 million in 2025.
  • Business Quant data shows Equity Average for GH at -$226.9 million in Q4 2025, -$330.0 million in Q3 2025, and -$278.1 million in Q2 2025.